IE 11 is a very old Browser and it`s not supported on this site

Consolidated statement of changes in equity

in CHF 1 000

Share capital

Treasury shares

Retained earnings

Total

Balances at January 1, 2023

11 080

(36 508)

2 711 563

2 686 135

Dividend (CHF 2.85 per share)

(156 311)

(156 311)

Total comprehensive income for the period

(253 855)

(253 855)

Balances at March 31, 2023

11 080

(36 508)

2 301 397

2 275 969

Balances at January 1, 2024

11 080

(36 508)

2 348 645

2 323 217

Dividend (CHF 2.00 per share)

(109 692)

(109 692)

Total comprehensive income for the period

260 494

260 494

Balances at March 31, 2024

11 080

(36 508)

2 499 447

2 474 019

The notes are an integral part of the condensed consolidated interim financial statements.

BB Biotech AG uses cookies to improve website usability and ensure the best possible user experience. Use of cookies & disclaimer